Skip to main navigation Skip to search Skip to main content

Sulfamates in drug design and discovery: Pre-clinical and clinical investigations

  • Faculty of Pharmacy
  • University of Sharjah

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Abstract

In the present article, we reviewed the sulfamate-containing compounds reported as bioactive molecules. The possible molecular targets of sulfamate derivatives include steroid sulfatase enzyme, carbonic anhydrases, acyl transferase, and others. Sulfamate derivatives can help treat hormone-dependent tumors including breast, prostate, and endometrial cancers, Binge eating disorder, migraine, glaucoma, weight loss, and epilepsy. Sulfamate derivatives can act also as calcium sensing receptor agonists and can aid in osteoporosis. Furthermore, acyl sulfamate derivatives can act as antibacterial agents against Gram-positive bacteria. A recent study revealed a new side effect of topiramate, a sulfamate-containing compound, which is sialolithiasis. The structural and biological characteristics of the reviewed compounds are presented in detail.

Original languageEnglish
Pages (from-to)257-271
Number of pages15
JournalEuropean Journal of Medicinal Chemistry
Volume179
DOIs
StatePublished - 1 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-cancer
  • Carbonic anhydrase
  • Irosustat
  • Steroid sulfatase
  • Sulfamate
  • Topiramate

Fingerprint

Dive into the research topics of 'Sulfamates in drug design and discovery: Pre-clinical and clinical investigations'. Together they form a unique fingerprint.

Cite this